P804: PLASMA CELL LEUKEMIA-LIKE TRANSCRIPTOME OF BONE MARROW PLASMA CELLS AND CIRCULATING TUMOR CELL LEVELS IN PERIPHERAL BLOOD COMPLEMENTARILY DEFINE HIGH-RISK IN NEWLY DIAGNOSED MULTIPLE MYELOMA

• Mattia D’agostino,
• Davine Hofste Op Bruinink,
• Mark van Duin,
• Delia Rota-Scalabrini,
• Luca Bertamini,
• Rowan Kuiper,
• Angelo Belotti,
• Vincenzo Marasco,
• Stefania Oliva,
• Elena Rivolti,
• Jennifer Rogers,
• Roberto Mina,
• Mariella Grasso,
• Antonio Ledda,
• Massimo Offidani,
• Monica Galli,
• Michele Cavo,
• Annemiek Broijl,
• Pellegrino Musto,
• Benedetto Bruno,
• Mario Boccadoro,
• Pieter Sonneveld,
• Francesca Gay

Affiliations

Mattia D’agostino

1 Contributed equally as joint first authors

Davine Hofste Op Bruinink

1 Contributed equally as joint first authors

Mark van Duin

4 Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, The Netherlands

Delia Rota-Scalabrini

5 Candiolo Cancer Institute, FPO-IRCCS, Medical Oncology Department, Torino, Italy

Luca Bertamini

2 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Rowan Kuiper

4 Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, The Netherlands

Angelo Belotti

7 ASST Spedali Civili di Brescia, Department of Hematology, Brescia, Italy

Vincenzo Marasco

8 Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan, Hematology and Bone Marrow Transplant Unit, Milan, Italy

Stefania Oliva

3 Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Division of Hematology, Torino, Italy

Elena Rivolti

9 Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy

Jennifer Rogers

10 Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, United States

Roberto Mina

2 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Mariella Grasso

11 Azienda Ospedaliera Santa Croce - Carle, S.C. Ematologia, Cuneo, Italy

Antonio Ledda

12 Ospedale “A. Businco”, Ematologia/CTMO, Cagliari, Italy

Massimo Offidani

13 AOU delle Marche, Ancona, Italy

Monica Galli

14 ASST Papa Giovanni XXIII, UO Ematologia, Bergamo, Italy

Michele Cavo

15 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy

Annemiek Broijl

4 Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, The Netherlands

Pellegrino Musto

17 ”Aldo Moro” University School of Medicine, Department of Precision and Regenerative Medicine and Ionian Area, Bari, Italy

Benedetto Bruno

2 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Mario Boccadoro

2 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Pieter Sonneveld

4 Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, The Netherlands

Francesca Gay

2 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy